Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 69,873 304.21 - 325.82
Mar 7, 2014 sanofi Beneficial Owner (10% or more) Buy 241,818 327.77 - 339.06
Mar 3, 2014 sanofi Beneficial Owner (10% or more) Buy 251,594 328.00 - 339.94
Feb 4, 2014 sanofi Beneficial Owner (10% or more) Buy 190,286 282.05 - 287.78
Feb 5, 2014 sanofi Beneficial Owner (10% or more) Buy 206,978 274.64 - 288.13
Feb 6, 2014 sanofi Beneficial Owner (10% or more) Buy 146,525 282.84 - 287.88
Feb 7, 2014 sanofi Beneficial Owner (10% or more) Buy 21,986 284.49 - 289.98
Jan 27, 2014 sanofi Beneficial Owner (10% or more) Buy 74,685 269.77 - 275.31
Jan 28, 2014 sanofi Beneficial Owner (10% or more) Buy 83,235 273.44 - 279.26
Jan 31, 2014 sanofi Beneficial Owner (10% or more) Buy 10,914 286.13 - 289.90
Feb 3, 2014 sanofi Beneficial Owner (10% or more) Buy 198,058 279.14 - 289.62
Oct 13, 2010 sanofi Beneficial Owner (10% or more) Buy 1,017,401 28.00
Jul 1, 2011 baker charles a Director Automatic Sell 11,000 55.94 - 57.40
Nov 26, 2012 baker charles a Director Automatic Sell 15,000 171.45 - 175.14
Sep 5, 2012 baker charles a Director Automatic Sell 1,286 150.00
Sep 6, 2012 baker charles a Director Automatic Sell 13,714 150.00
Apr 17, 2012 baker charles a Director Automatic Sell 2,090 125.00
Apr 19, 2012 baker charles a Director Automatic Sell 12,910 125.00
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
Sep 30, 2013 baker charles a Director Automatic Sell 15,000 302.46 - 319.13
Showing 41-60 of 1039 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)